KOCHI: 68-year-old Thankamma (name changed) from Ernakulam has been a diabetic patient for 15 years. As she did not manage ...

EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

and due to proliferative diabetic retinopathy. Vision loss due to DR is preventable with the appropriate monitoring and timely treatment. Improved patient and health professional, education to ...

The following is a summary of “Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in ...

Other patients may have no symptoms with their retinopathy discovered only in screening. "It would be wonderful to never need to treat any 20-year-olds with proliferative diabetic retinopathy who ...

Diabetic retinopathy is a leading cause of vision loss among adults and often goes unnoticed until it reaches advanced stages ...

Steve Myers; Chief Commercial Officer; Ocular Therapeutix Inc Biren Amin; Analyst; Piper Sandler Companies Yi Chen; Analyst; H.C. Wainwright ...

ABBV-RGX-314, administered once within an office setting, can significantly improve disease severity in patients with NPDR.

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients ...

In October, Ocuphire Pharma acquired Opus Genetics, creating a leading, clinical-stage company focused on the development of gene therapy ...

He pointed that out subsequent studies found that have many of the patients who had these complications had preexisting diabetic retinopathy or even proliferative disease at the time of entry into the ...

Any of these retinal issues can cause problems with your sight. The two types of diabetic retinopathy are nonproliferative and proliferative. The nonproliferative form of the disease occurs first.